NEWME and NEwMe diabetes
A Digital Therapeutics (DTx) Platform
The prevention & management of chronic diseases has been the focus of Eco-Fusion’s Digital Therapeutics for a good reason. The gold standard treatment of such conditions is largely based on guiding the patient through the process of acquiring healthier habits related to nutrition, exercise & medication adherence. Eco Fusion is adding a set of patented technologies for dealing with stress, sleep and general wellbeing. Our solution was shown to be clinically effective in reducing blood sugar of Type II patient by 18% within 8 weeks (a published article on the Journal of Medical Internet Research, 2017).
NewMe™ is an app & a web platform that connects patients and caregivers. It allows a medical professional or a team to deliver treatment, monitor its efficacy, and adjust it on a daily basis. The system provides a comprehensive overview of the patient’s health and progress. Treatment adjustments can be done with a few mouse clicks and delivered to the patient instantly.
These capabilities help improve diagnosis and treatment and enable scalability & long-term success. The platform has multiple programs such as NewMe Diabetes and could be customized to a variety of other indications. For example, our solution was clinically validated and shown to reduce a1c and weight within 8 weeks (with sustainability after 16 weeks and 6 months).
Data-source: Smartphone sensors, apps, wearables, wireless medical devices such as Digital Scales, Glucose and Blood Pressure monitors and Electronic Medical Records.
NewMe and NewMe Diabetes are oferred only through health organizations
If your organization is interested in offering NewMe to its patients, we invite you to contact us.